The U.S. government launched an ambitious push to develop new treatments for Alzheimer’s on Tuesday with a first prevention study of high-risk patients and tests on an insulin nasal spray that has shown promise in earlier studies.

The trials, funded by grants of $16 million and $7.9 million respectively, are part of a national…